logo-loader

OptiBiotix Health signs manufacturing and supply agreement with US Pharma Lab

Published: 14:41 09 Oct 2018 BST

Per Rehne, chief commercial director of OptiBiotix Health plc (LON:OPTI), discusses with Proactive's Andrew Scott a manufacturing and supply agreement they've signed with a US-based probiotic maker for its LPLDL probiotic strain.

Rehne says under the agreement, US Pharma Lab Inc (USPL) will be granted non-exclusive rights to manufacture and supply formulations containing the LPLDL strain.

Caledonia Mining tackles 2023 challenges with optimism for 2024 as it...

Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) chief executive Mark Learmonth tells Proactive's Stephen Gunnion the company faced a challenging 2023, primarily due to poor production in the first half of the year at its core asset, the Blanket Mine in Zimbabwe, and an underperformance...

1 hour, 50 minutes ago